Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCann, S. E.
Right arrow Articles by Shields, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCann, S. E.
Right arrow Articles by Shields, P. G.

© 2002 The American Society for Nutritional Sciences J. Nutr. 132:3036-3041, October 2002


Nutrient-Gene Interactions

The Risk of Breast Cancer Associated with Dietary Lignans Differs by CYP17 Genotype in Women1

Susan E. McCann2, Kirsten B. Moysich*, Jo L. Freudenheim, Christine B. Ambrosone{dagger} and Peter G. Shields**

Department of Social and Preventive Medicine, University at Buffalo, Buffalo, NY 14214; * Department of Cancer Prevention, Epidemiology and Biostatistics, Roswell Park Cancer Institute, Buffalo, NY 14263; {dagger} Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, NY 10029; and ** Division of Cancer Genetics and Epidemiology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007

2To whom correspondence should be addressed. E-mail: mccann{at}acsu.buffalo.edu.

Lignans are plant compounds metabolized in the gut to produce the phytoestrogens enterolactone and enterodiol. Reduced breast cancer risks associated with higher urinary lignan excretion may be related to competitive inhibition of endogenous estrogens. Evidence exists that associations with reproductive risk factors for breast cancer differ according to cytochrome P450c17{alpha} (CYP17) genotype. Genetic variability in estrogen metabolism could affect lignan metabolism thereby modifying risk associations. We examined breast cancer risk, dietary lignans and CYP17 genotype among 207 women with primary, incident, histologically confirmed breast cancer and 188 controls frequency matched to cases by age and county of residence. Self-reported frequency of intake of 170 foods and beverages during the 2 y before the interview and other relevant data were collected by detailed in-person interviews. Dietary lignan intake was expressed as the sum of enterolactone and enterodiol production from foods. Odds ratios (OR) and 95% confidence intervals (CI) were estimated by unconditional logistic regression, adjusting for age, education and other breast cancer risk factors. Women in the highest tertile of dietary lignans tended to have reduced breast cancer risk (OR 0.45, 95% CI 0.20–1.01 and OR 0.59, 95% CI 0.28–1.27, pre- and postmenopausal women, respectively). Substantially reduced risks in the highest tertile of lignans were observed for premenopausal women with at least one A2 allele (OR 0.12, 95% CI 0.03–0.50). Our results suggest that CYP17 genotype may be important in modifying the effect on breast cancer risk of exogenous estrogens, particularly for premenopausal women.


KEY WORDS: • phytoestrogens • CYP17 • breast cancer • humans




This article has been cited by other articles:


Home page
J. Nutr.Home page
M. Hedelin, M. Lof, M. Olsson, H. Adlercreutz, S. Sandin, and E. Weiderpass
Dietary Phytoestrogens Are Not Associated with Risk of Overall Breast Cancer But Diets Rich in Coumestrol Are Inversely Associated with Risk of Estrogen Receptor and Progesterone Receptor Negative Breast Tumors in Swedish Women
J. Nutr., May 1, 2008; 138(5): 938 - 945.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
C. Duffy, K. Perez, and A. Partridge
Implications of Phytoestrogen Intake for Breast Cancer
CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
B. N. Fink, S. E. Steck, M. S. Wolff, J. A. Britton, G. C. Kabat, J. C. Schroeder, S. L. Teitelbaum, A. I. Neugut, and M. D. Gammon
Dietary Flavonoid Intake and Breast Cancer Risk among Women on Long Island
Am. J. Epidemiol., March 1, 2007; 165(5): 514 - 523.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Verheus, C. H. van Gils, L. Keinan-Boker, P. B. Grace, S. A. Bingham, and P. H.M. Peeters
Plasma Phytoestrogens and Subsequent Breast Cancer Risk
J. Clin. Oncol., February 20, 2007; 25(6): 648 - 655.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. E. McCann, J. Wactawski-Wende, K. Kufel, J. Olson, B. Ovando, S. N. Kadlubar, W. Davis, L. Carter, P. Muti, P. G. Shields, et al.
Changes in 2-Hydroxyestrone and 16{alpha}-Hydroxyestrone Metabolism with Flaxseed Consumption: Modification by COMT and CYP1B1 Genotype
Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. T Zarrabeitia, J. L Hernandez, C. Valero, A. Zarrabeitia, J. A Amado, J. Gonzalez-Macias, and J. A Riancho
Adiposity, estradiol, and genetic variants of steroid-metabolizing enzymes as determinants of bone mineral density
Eur. J. Endocrinol., January 1, 2007; 156(1): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Touillaud, A. C.M. Thiebaut, M. Niravong, M.-C. Boutron-Ruault, and F. Clavel-Chapelon
No Association between Dietary Phytoestrogens and Risk of Premenopausal Breast Cancer in a French Cohort Study
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2574 - 2576.
[Full Text] [PDF]


Home page
J. Nutr.Home page
R. Piller, E. Verla-Tebit, S. Wang-Gohrke, J. Linseisen, and J. Chang-Claude
CYP17 Genotype Modifies the Association between Lignan Supply and Premenopausal Breast Cancer Risk in Humans
J. Nutr., June 1, 2006; 136(6): 1596 - 1603.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Stuedal, I. T. Gram, Y. Bremnes, H. Adlercreutz, M. B. Veierod, and G. Ursin
Plasma Levels of Enterolactone and Percentage Mammographic Density among Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2154 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. U. Thompson, J. M. Chen, T. Li, K. Strasser-Weippl, and P. E. Goss
Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer
Clin. Cancer Res., May 15, 2005; 11(10): 3828 - 3835.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. E. J. Milder, E. J. M. Feskens, I. C. W. Arts, H. B. B. de Mesquita, P. C. H. Hollman, and D. Kromhout
Intake of the Plant Lignans Secoisolariciresinol, Matairesinol, Lariciresinol, and Pinoresinol in Dutch Men and Women
J. Nutr., May 1, 2005; 135(5): 1202 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. C. Arts and P. C. Hollman
Polyphenols and disease risk in epidemiologic studies
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 317S - 325S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Olsen, K. E. B. Knudsen, B. L. Thomsen, S. Loft, C. Stripp, K. Overvad, S. Moller, and A. Tjonneland
Plasma Enterolactone and Breast Cancer Incidence by Estrogen Receptor Status
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2084 - 2089.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Sharp, A. H. Cardy, S. C. Cotton, and J. Little
CYP17 Gene Polymorphisms: Prevalence and Associations with Hormone Levels and Related Factors. A HuGE Review
Am. J. Epidemiol., October 15, 2004; 160(8): 729 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. F. Johnsen, H. Hausner, A. Olsen, I. Tetens, J. Christensen, K. E. B. Knudsen, K. Overvad, and A. Tjonneland
Intake of Whole Grains and Vegetables Determines the Plasma Enterolactone Concentration of Danish Women
J. Nutr., October 1, 2004; 134(10): 2691 - 2697.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Hausner, N. F. Johnsen, J. Hallund, and I. Tetens
A Single Measurement Is Inadequate to Estimate Enterolactone Levels in Danish Postmenopausal Women Due to Large Intraindividual Variation
J. Nutr., May 1, 2004; 134(5): 1197 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. G Ziegler
Phytoestrogens and breast cancer
Am. J. Clinical Nutrition, February 1, 2004; 79(2): 183 - 184.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Keinan-Boker, Y. T van Der Schouw, D. E Grobbee, and P. H. Peeters
Dietary phytoestrogens and breast cancer risk
Am. J. Clinical Nutrition, February 1, 2004; 79(2): 282 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. N. Begum, C. Nicolle, I. Mila, C. Lapierre, K. Nagano, K. Fukushima, S.-M. Heinonen, H. Adlercreutz, C. Remesy, and A. Scalbert
Dietary Lignins Are Precursors of Mammalian Lignans in Rats
J. Nutr., January 1, 2004; 134(1): 120 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Kilkkinen, L. M. Valsta, J. Virtamo, K. Stumpf, H. Adlercreutz, and P. Pietinen
Intake of Lignans Is Associated with Serum Enterolactone Concentration in Finnish Men and Women
J. Nutr., June 1, 2003; 133(6): 1830 - 1833.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. E. McCann, J. L. Freudenheim, J. R. Marshall, and S. Graham
Risk of Human Ovarian Cancer Is Related to Dietary Intake of Selected Nutrients, Phytochemicals and Food Groups
J. Nutr., June 1, 2003; 133(6): 1937 - 1942.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2002 by American Society for Nutrition